Marc W. Hentz

Deutsche Bank AG (Broker) is the brokerage arm of Deutsche Bank AG (ETR: DBK) in Germany. Headquartered in Frankfurt, the firm was founded in 1870 and offers FX Prime Brokerage (FXPB) which enables clients to transact foreign exchange across an array of dealers utilizing Deutsche Bank credit lines to maintain anonymity, maximize operational and margin efficiency and reduce transactional costs.

Biotype GmbH is a German molecular diagnostics company that specializes in developing, producing, and distributing molecular diagnostic solutions for the detection and quantification of RNA and DNA markers. The private company is based in Dresden, Germany and was founded in 1999 by Jörg Gabert and Wilhelm Zörgiebel. The company's assays support diagnosis and therapy in oncology, haemato-oncology, dermatology, and infectious diseases. The company uses their many years of experience in the development and production of test systems in DNA analysis to set new standards in the area of multiparameter diagnosis for the early and rapid clarification of various medical questions. The company's Mentype® products are essential tools for doctors in the areas of leukemia, oncology, and dermatology. The company has recently offered their expertise in the form of new DNA extraction systems for the preparation of various biological sample materials. Wilhelm Zörgiebel has been the CEO since 1999.